HQL
Tekla Life Sciences Investors
18.50$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| 472.2% | 427.0% | 78.7% | 6.6% | 240.3% | – | 3.9% | 8.5% | – | 22.3% | 6.2% | 5.8% | |
| -372.2% | -327.0% | 21.3% | 93.4% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | 0.0% | – | – | |
| 529.5% | 457.0% | 83.1% | 1.4% | 281.6% | – | 0.6% | 1.3% | – | 3.8% | 1.5% | 0.9% | |
| 10,081.2% | 2,962.1% | 212.2% | 1.8% | 281.6% | – | 0.8% | 1.8% | – | 5.0% | 1.6% | 0.9% | |
| -429.5% | -357.0% | -60.3% | -5.6% | -181.6% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| 10,610.3% | 3,419.1% | 129.1% | 103.8% | 1,625.1% | – | 0.0% | 0.0% | – | – | – | – | |
| 10,181.2% | 3,062.1% | -189.3% | 98.2% | 1,443.4% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| 10,610.7% | 3,419.1% | 418.3% | 0.0% | 0.0% | – | -1.7% | -6.3% | – | 95.0% | – | – | |
| 10,181.2% | 3,062.1% | -189.3% | 98.2% | 1,443.4% | – | 99.2% | 98.2% | – | 95.0% | 98.4% | 99.1% | |
| 20,791.8% | 6,481.2% | -318.4% | 98.2% | 3,068.5% | – | 99.2% | 98.2% | – | 95.0% | 100.6% | 99.1% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.